Photo of Brian Patrick Tullius, MD

Brian Patrick Tullius, MD

Physician

Research Area:

Expertise of Brian Patrick Tullius, MD

4 items. To interact with these items, press Control-Option-Shift-Right Arrow
Item 1 of 4
Biography

Brian Tullius, MD, is a board-certified pediatrician. Dr. Tullius received his medical degree at the University of Nebraska College of Medicine in Omaha Nebraska after completing a Master of Arts degree in Philosophy and a Bachelor of Arts in Philosophy and Biology from Franciscan University of Steubenville in Steubenville, Ohio. He has extensive training in pediatrics, completing pediatric internship at the Naval Medical Center in San Diego and pediatric residency at the University of California-Davis Medical Center in Sacramento. Dr. Tullius completed flight surgeon training at the Naval Aerospace Medical Institute in Pensacola, FL, and his pediatric hematology/oncology as well as his cellular therapy fellowships at Nationwide Children’s Hospital in Columbus, Ohio. He served in the United States Navy achieving the rank of Lieutenant Commander and receiving numerous awards and commendations for his outstanding service. Dr. Tullius has a U.S. Patent on a cellular therapy for treating microbial infections, and a patent pending for an innovative website he helped design to improve access to and awareness of clinical trials. An accomplished medical practitioner, Dr. Tullius specializes in cellular therapies, cancer immunotherapy, innate immunity and stem cell transplantation.

Item 2 of 4
Education

University of Nebraska College of Medicine, Omaha, NE

Item 3 of 4
Residency

Pediatrics at UC Davis School of Medicine

Item 4 of 4
Fellowship

Bone Marrow at Nationwide Children's Hospital

Publications of Brian Patrick Tullius, MD
  • Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies
    , JOURNAL FOR IMMUNOTHERAPY OF CANCER

  • CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy
    , FRONTIERS IN ONCOLOGY

  • Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
    , STEM CELL RESEARCH & THERAPY

    More sources loaded

  • COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
    , JOURNAL OF INFECTION

  • Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity
    , SEMINARS IN HEMATOLOGY

  • Natural Killer Cell Immunotherapy for Osteosarcoma
    , CURRENT ADVANCES IN OSTEOSARCOMA: CLINICAL PERSPECTIVES: PAST, PRESENT AND FUTURE, 2ND EDITION

  • Therapeutic modulation of the CD47-SIRPalpha axis in the pediatric tumor microenvironment: working up an appetite.
    , Cancer drug resistance (Alhambra, Calif.)

  • Novel heterozygous mutation in the PTEN gene associated with ovarian germ cell tumor complicated by growing teratoma syndrome and overgrowth in a two-year-old female
    , PEDIATRIC BLOOD & CANCER

  • Hospital-to-Home Interventions, Use, and Satisfaction: A Meta-analysis
    , PEDIATRICS

  • The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH
    , JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Associated Clinical Trials for Brian Patrick Tullius, MD